Reduction of Natural Adenovirus Tropism to Mouse Liver by Fiber-Shaft Exchange in Combination with both CAR- and αv Integrin-Binding Ablation

Journal of Virology

Volumn 77, Issue 24, 2003, Pages 13062-13072

  Koizumi, Naoya ^a   Mizuguchi, Hiroyuki ^a,b   Sakurai, Fuminori ^a   Yamaguchi, Teruhide ^a   Watanabe, Yoshiteru ^c   Hayakawa, Takao ^b  

^a Div of Cell and Gene Ther Prod   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA5 INTEGRIN; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RECEPTOR;

ADENOVIRUS 5; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; EMBRYO; GENE EXPRESSION; HEART; HUMAN; HUMAN CELL; KIDNEY; LIVER; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SPLEEN; VIROGENESIS; VIRUS MUTATION; VIRUS STRAIN;

ADENOVIRIDAE INFECTIONS; ADENOVIRUSES, HUMAN; AMINO ACID SEQUENCE; ANIMALS; CAPSID PROTEINS; CELL LINE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTEGRIN ALPHAV; LIVER; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUTATION; RECEPTORS, VIRUS; TRANSDUCTION, GENETIC;

EID: 0344304662     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.24.13062-13072.2003     Document Type: Article

References (50)

1. Alemany, R, and D. T. Curiel. 2001. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther. 8:1347-1353.
2. Alemany, R., K. Suzuki, and D. T. Curiel. 2000. Blood clearance rates of adenovirus type 5 in mice. J. Gen. Virol. 81:2605-2609.
3. Aoki, K., S. Furuhata, K. Hatanaka, M. Maeda, J. S. Remy, J. P. Behr, M. Terada, and T. Yoshida. 2001. Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity. Gene Ther. 8:508-514.
4. Asaoka, K., M. Tada, Y. Sawamura, J. Ikeda, and H. Abe. 2000. Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the coxsackievirus and adenovirus receptor. J. Neurosurg. 92:1002-1008.
5. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
6. Bewley, M. C., K. Springer, Y. B. Zhang, P. Freimuth, and J. M. Flanagan. 1999. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 286:1579-1583.
7. Douglas, J. T., C. R. Miller, M. Kim, I. Dmitriev, G. Mikheeva, V. Krasnykh, and D. T. Curiel. 1999. A system for the propagation of adenoviral vectors with genetically modified receptor specificities. Nat. Biotechnol. 17:470-475.
8. Einfeld, D. A., R. Schroeder, P. W. Roelvink, A. Lizonova, C. R. King, I. Kovesdi, and T. J. Wickham. 2001. Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions, J. Virol. 75:11284-11291.
9. Fechner, H., A. Haack, H. Wang, X. Wang, K. Eizema, M. Pauschinger, R. Schoemaker, R. Veghel, A. Houtsmuller, H. P. Schultheiss, J. Lamers, and W. Poller. 1999. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther. 6:1520-1535..
10. Heffelfinger, S. C., H. H. Hawkins, J. Barrish, L. Taylor, and G. J. Darlington. 1992. SK HEP-1: a human cell line of endothelial origin. In Vitro Cell Dev. Biol. 28A:136-142.
11. Hegenbarth, S., R. Gerolami, U. Protzer, P. L. Tran, C. Brechot, G. Gerken, and P. A. Knolle. 2000, Liver sinusoidal endothelial cells ate not permissive for adenovirus type 5. Hum. Gene Ther. 11:481-486.
12. Henry, L. J., D. Xia, M. E. Wilke, J. Deisenhofer, and R. D. Gerard. 1994. Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J. Virol. 68:5239-5246.
13. Hong, S. S., M. K. Magnusson, P. Henning, L. Lindholm, and P. A. Boulanger. 2003. Adenovirus stripping: a versatile method to generate adenovirus vectors with new cell target specificity. Mol. Ther. 7:692-699.
14. Huard, J., H. Lochmuller, G. Acsadi, A. Jani, B. Massie, and G. Karpati. 1995. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 2:107-115
15. Kanerva, A., M. Wang, G. J. Bauerschmitz, J. T. Lam, R. A. Desmond, S. M. Bhoola, M. N. Barnes, R. D. Alvarez, G. P. Siegal, D. T. Curiel, and A. Hemminki. 2002. Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses. Mol. Ther. 5:695-704.
16. Kirby, I., E. Davison, A. J. Beavil, C. P. C. Soh, T. J. Wickham, P. W. Roelvink, I. Kovesdi, B. J. J. Sutton, and G. Santis. 1999. Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR. J. Virol. 73:9508-9514.
17. Koizumi, N., H. Mizuguchi, T. Hosono, A. Ishii-Watabe, E. Uchida, N. Utoguchi, Y. Watanabe, and T. Hayakawa. 2001. Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide. Biochim. Biophys. Acta 1568:13-20.
18. Koizumi, N., H. Mizuguchi, N. Utoguchi, Y. Watanabe, and T. Hayakawa. 2003. Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob. J. Gene Med. 5:267-276.
19. Krasnykh, V., N. Belousova, N. Korokhov, G. Mikheeva, and D. T. Curiel. 2001. Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J. Virol. 75:4176-4183.
20. Krasnykh, V. N., J. T. Douglas, and V. W. van Beusechem. 2000. Genetic targeting of adenoviral vectors. Mol. Ther. 1:391-405.
21. Kuzmin, A., M. Finegold, and R. Eisensmith. 1997. Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo. Gene Ther. 4:309-316.
22. Kuzmin, A. I., O. Galenko, and R. C. Eisensmith. 2001. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors. Mol. Ther. 3:293-301.
23. Legrand, V., D. Spehner, Y. Schlesinger, N. Settelen, A. Pavirani, and M. Mehtali. 1999. Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber. J. Virol. 73:907-919.
24. Leissner, P., V. Legrand, Y. Schlesinger, D. A. Hadji, M. van Raaij, S. Cusack, A. Pavirani, and M. Mehtali. 2001. Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism. Gene Ther. 8:49-57.
25. Lieber, A., C. He, L. Meuse, D. Schowalter, I. Kirillova, B. Winther, and M. Kay. 1997. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 71:8798-8807.
26. Magnusson, M. K., S. S. Hong, P. Henning, P. Boulanger, and L. Lindholm. 2002. Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability. J. Gene Med. 4:356-370.
27. Maizel, J. V. J., D. O. White, and M. D. Scharff. 1968. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 36:115-125.
28. Mizuguchi, H., and T. Hayakawa. 2002. Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes. Gene 285:69-77.
29. Mizuguchi, H., and T. Hayakawa. 2002. Enhanced anti-tumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase. Cancer Gene Ther. 9:236-242.
30. Mizuguchi, H., and M. A. Kay. 1998. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum. Gene Ther. 9:2577-2583.
31. Mizuguchi, H., and M. A. Kay. 1999. A simple method for constructing E1 and E1/E4 deleted recombinant adenovirus vector. Hum. Gene Ther. 10:2013-2017.
32. Mizuguchi, H., N. Koizumi, T. Hosono, A. Ishii-Watabe, E. Uchida, N. Utoguchi, Y. Watanabe, and T. Hayakawa. 2002. CAR- or αv integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice. Gene Ther. 9:769-776.
33. Mizuguchi, H., N. Koizumi, T. Hosono, N. Utoguchi, Y. Watanabe, M. A. Kay, and T. Hayakawa. 2001. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther. 8:730-735.
34. Nakamura, T., K. Sato, and H. Hamada. 2003. Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber. J. Virol. 77:2512-2521.
35. Nishikawa, M., S. Takemura, Y. Takakura, and M. Hashida. 1998. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. J. Pharm. Exp. Ther. 287:408-415.
36. Peng, K. W., L. Pham, H. Ye, R. Zufferey, D. Trono, F. L. Cosset, and S. J. Russell. 2001. Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Ther. 8:1456-1463.
37. Roelvink, P. W., G. Mi Lee, D. A. Einfeld, I. Kovesdi, and T. J. Wickham. 1999. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 286:1568-1571.
38. Schiedner, G., S. Hertel, M. Johnston, V. Dries, N. van Rooijen, and S. Kochanek. 2003. Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors. Mol. Ther. 7:35-43.
39. Shayakhmetov, D. M., and A. Lieber. 2000. Dependence of adenovirus infectivity on length of the fiber shaft domain. J. Virol. 74:10274-10286.
40. Smith, T., N. Idamakanti, H. Kylefjord, M. Rollence, L. King, M. Kaloss, M. Kaleko, and S. C. Stevenson. 2002. In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor. Mol. Ther. 5:770-779.
41. Smith, T. A. G., N. Idamakanti, M. L. Rollence, J. Marshall-Neff, J. Kim, K. Mulgrew, G. R. Nemerow, M. Kaleko, and S. C. Stevenson. 2003. Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice. Hum. Gene Ther. 14:777-787.
42. Tomko, R. P., R. Xu, and L. Philipson. 1997. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. USA 94:3352-3356.
43. Vigne, E., J. F. Dedieu, A. Brie, A. Gillardeaux, D. Briot, K. Benihoud, M. Latta-Mahieu, P. Saulnier, M. Perricaudet, and P. Yeh. 2003. Genetic manipulations of adenovirus type 5 fiber resulting in liver tropism attenuation. Gene Ther. 10:153-162.
44. Von Seggern, D. J., J. Kehler, R. I. Endo, and G. R. Nemerow. 1998. Complementation of a fibre mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fibre protein. J. Gen. Virol. 79:1461-1468.
45. Wickham, T. J. 2000. Targeting adenovirus. Gene Ther. 7:110-114.
46. Wickham, T. J., E. J. Filardo, D. A. Cheresh, and G. R. Nemerow. 1994. Integrin αvΒ5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127:257-264.
47. Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins αvΒ3 and αvΒ5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
48. Wood, M., P. Perrotte, E. Onishi, M. E. Harper, C. Dinney, L. Pagliaro, and D. R. Wilson. 1999. Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Cancer Gene Ther. 6:367-372.
49. Worgall, S., G. Wolff, E. Falck-Pedersen, and R. Crystal. 1997. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8:37-44.
50. Xu, Z.-L., H. Mizuguchi, A. Ishii-Watabe, E. Uchida, T. Mayumi, and T. Hayakawa. 2001. Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene 272:149-156.